Literature DB >> 22039814

Current status and future prospects for research on tyrosine sulfation.

Nobuya Sasaki1.   

Abstract

Tyrosine (Tyr) sulfation is a common posttranslational modification of secreted proteins or membrane-bound proteins that is implicated in numerous physiological and pathological processes. The Tyr sulfation modifies proteinprotein interactions involved in leukocyte adhesion, homeostasis, and receptor-mediated signaling. To data, 80 Tyrsulfated proteins have been identified. As new methodologies and bioinformatics for the detection of Tyr sulfation become available, the number of Tyr-sulfated acceptor proteins discovered is bound to increase. Further, recent advances in microscopy and fluorescence technology will provide information on the true spatial and temporal nature of Tyr-sulfated proteins within the intact cell. This review summarizes the methods for the detection of Tyr O-sulfation as well as the biological functions of sulfated Tyr. Further, illustrative examples of the impact of Tyr sulfation on the pharmacological properties are presented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22039814     DOI: 10.2174/138920101314151120122922

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  6 in total

1.  From sequence and forces to structure, function, and evolution of intrinsically disordered proteins.

Authors:  Julie D Forman-Kay; Tanja Mittag
Journal:  Structure       Date:  2013-09-03       Impact factor: 5.006

Review 2.  Synthetic approaches to protein phosphorylation.

Authors:  Zan Chen; Philip A Cole
Journal:  Curr Opin Chem Biol       Date:  2015-07-18       Impact factor: 8.822

3.  Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier.

Authors:  Horace T B Ho; Amber Dahlin; Joanne Wang
Journal:  Front Pharmacol       Date:  2012-08-24       Impact factor: 5.810

4.  Single-residue posttranslational modification sites at the N-terminus, C-terminus or in-between: To be or not to be exposed for enzyme access.

Authors:  Fernanda L Sirota; Sebastian Maurer-Stroh; Birgit Eisenhaber; Frank Eisenhaber
Journal:  Proteomics       Date:  2015-07       Impact factor: 3.984

Review 5.  Advances in Fmoc solid-phase peptide synthesis.

Authors:  Raymond Behrendt; Peter White; John Offer
Journal:  J Pept Sci       Date:  2016-01       Impact factor: 1.905

6.  Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease.

Authors:  Shuai Chen; Yong-Hua Liu; Dao-Peng Dai; Zheng-Bin Zhu; Yang Dai; Zhi-Ming Wu; Li-Ping Zhang; Zhi-Feng Duan; Lin Lu; Feng-Hua Ding; Jin-Zhou Zhu; Rui-Yan Zhang
Journal:  BMC Nephrol       Date:  2021-02-23       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.